Abstract
Background: Autoantibodies against the postsynaptic glycine receptor were recently reported in patients with variants of stiff-person syndrome (SPS). The glycine receptor was presumed an autoantibody target because several mutations in its two subunits are associated with hereditary hyperekplexia, which in some instances resembles SPS. In a cohort of patients with SPS and related movement disorders, we report autoantibodies against two further proteins of inhibitory glycinergic synapses, glycine receptor-clustering gephyrin and presynaptic glycine transporter 2 (GlyT2/SLC6A5).
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.